Deciding to Ditch Latin

A report details how the International Botanical Congress agreed in favor of electronic-only publication and naming new species using English.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Nomenclature Section of the XVIII International Botanical Congress, Melbourne, Australia, July 2011IBC2011, MICHAEL SILVER/PHOTONETThree summers ago, the International Botanical Congress met in Melbourne, Australia, to discuss, among other things, the future of plant nomenclature. After 10 sessions, the group decided that new species of plants, fungi, and algae could be published electronically only and named using English. In a report published last week (April 29) in PhytoKeys, Christina Flann from Wageningen University in the Netherlands, Nicholas Turland of the Botanic Garden and Botanic Museum Berlin-Dahlem, Germany, and Anna Monro of the Centre for Australian National Biodiversity Research in Canberra described the weeklong deliberations that went into this decision.

Delegate Peter Wilson of Australia told the group he “believed that English now occupied a place in scientific communication that Latin occupied in Linnaeus’s day,” according to the authors.

“Permitting electronic-only publication was arguably the most important decision made in Melbourne, bringing taxonomy into the 21st century and the electronic age,” Turland said in a statement. “As for Latin, it has become increasingly difficult to use and is often regarded as an irrelevant anachronism by modern scientists. The meeting clearly wanted an alternative.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies